Buisset, A
Because the peptide is not FDA-approved, it exists in a regulatory gray area
The unregulated research chemical market contains products of widely varying quality, and poor-quality peptides can completely explain treatment failures
When choosing a local clinic, it's essential to research their credentials, read reviews, and ensure they have qualified healthcare professionals administering the injections
Contact your GP or prescribing clinician if you experience : Severe or worsening fatigue that significantly impairs daily activities or persists beyond several weeks of treatment Extreme weakness or inability to perform usual tasks Dizziness or fainting , particularly on standing, which may indicate dehydration or blood pressure changes Persistent nausea or vomiting preventing adequate food or fluid intake Signs of dehydration : dark urine, reduced urination, dry mouth, confusion Chest pain, palpitations, or breathlessness accompanying tiredness Mood changes , including low mood or depression, which can manifest as fatigue Right upper abdominal pain, fever or yellowing of the skin/eyes , which could indicate gallbladder problems (GLP-1 medications may increase gallstone risk) For urgent but non-emergency concerns, you can contact NHS 111 for advice
Both peptides are once-weekly
